Adage Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-102,898
| Closed | -$6.88M | – | 930 |
|
|
2024
Q3 | $6.88M | Sell |
102,898
-149,555
| -59% | -$9.99M | 0.01% | 678 |
|
|
2024
Q2 | $30M | Buy |
+252,453
| New | +$30M | 0.06% | 334 |
|
|
2024
Q1 | – | Sell |
-249,453
| Closed | -$24.8M | – | 925 |
|
|
2023
Q4 | $24.8M | Sell |
249,453
-63,763
| -20% | -$6.34M | 0.05% | 362 |
|
|
2023
Q3 | $32.4M | Buy |
313,216
+55,191
| +21% | +$5.7M | 0.07% | 275 |
|
|
2023
Q2 | $31.4M | Sell |
258,025
-33,973
| -12% | -$4.13M | 0.07% | 290 |
|
|
2023
Q1 | $44.8M | Sell |
291,998
-44,018
| -13% | -$6.76M | 0.1% | 236 |
|
|
2022
Q4 | $60.4M | Buy |
336,016
+3,300
| +1% | +$593K | 0.14% | 171 |
|
|
2022
Q3 | $39.3M | Buy |
332,716
+205,258
| +161% | +$24.3M | 0.1% | 223 |
|
|
2022
Q2 | $18.2M | Sell |
127,458
-230,858
| -64% | -$33M | 0.04% | 454 |
|
|
2022
Q1 | $61.7M | Sell |
358,316
-17,600
| -5% | -$3.03M | 0.12% | 180 |
|
|
2021
Q4 | $95.5M | Buy |
375,916
+48,788
| +15% | +$12.4M | 0.17% | 127 |
|
|
2021
Q3 | $126M | Buy |
+327,128
| New | +$126M | 0.25% | 87 |
|
|
2020
Q3 | – | Sell |
-325,000
| Closed | -$20.9M | – | 795 |
|
|
2020
Q2 | $20.9M | Buy |
+325,000
| New | +$20.9M | 0.05% | 376 |
|